Sökresultat - "cadonilimab"

Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study

Wang, Yilin^{Aff1, Aff2}, Pan, Shida^Aff3, Tian, Jiahe^Aff4, Wang, Jianing, Yu, Yingying, Wang, Siyu, Li, Fengyi, Yang, Luo, Liu, Xiaomeng, Shen, Yingjuan, Qiu, Qin, Luan, Junqing, Jia, Mengdie, Xiong, Chuyue, Duan, Xuanxuan, Wang, Fu-Sheng^{Aff1, Aff2, IDs00262025040388_cor1}, Meng, Fanping^{Aff1, Aff2, IDs00262025040388_cor2}

Pyrotinib monotherapy for advanced HER2-positive esophageal adenocarcinoma with trastuzumab resistance and chemotherapy intolerance: a case report and literature review

Tao Wang, Mingyuan He, Wei Guan

electronic resource

Visa

Efficacy and safety of cadonilimab (PD-1/CTLA-4 bispecific) in combination with chemotherapy in anti-PD-1-resistant recurrent or metastatic nasopharyngeal carcinoma: a single-arm, open-label, phase 2 trial

Yaofei Jiang, Weixin Bei, Lin Wang, Nian Lu, Cheng Xu, Hu Liang, Liangru Ke, Yanfang Ye, Shuiqing He, Shuhui Dong, Qin Liu, Chuanrun Zhang, Xuguang Wang, Weixiong Xia, Chong Zhao, Ying Huang, Yanqun Xiang, Guoying Liu

electronic resource

Visa

Cost-effectiveness analysis of first-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma

Zhifeng Zhou, Yanqing Yang, Shaofang Chen, Maojin You

electronic resource

Visa; Visa

Cadonilimab plus chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer: a cost-effectiveness analysis

Zuojuan Xiang, Zhengxiong Li, Xiaojuan Chen, Yingzhou Fu

electronic resource

Visa; Visa

The efficacy and safety of a novel PD‐1/CTLA‐4 bispecific antibody cadonilimab (AK104) in advanced non‐small cell lung cancer: A multicenter retrospective observational study

Hongxin Li, Wen Zhao, Chengming Li, Hongchang Shen, Meiying Li, Chengjun Wang, Chunyan Han, Cuihua Yi, Jun Wang, Xue Meng, Lian Liu, Shuwen Yu, Jisheng Li

electronic resource

Visa; Visa

Oral Lichenoid lesions induced by programmed cell death protein 1 and cytotoxic T-lymphocyte-associated protein 4 bispecific antibody: a case report

Qiaozhi Jiang, Xinyu Chen, Jiaxuan Wu, Shanni Wei, Renchuan Tao

electronic resource

Visa

Nab-paclitaxel combined with cadonilimab (AK104) as second-line treatment for advanced gastric cancer: protocol for a phase II prospective, multicenter, single-arm clinical trial

Jing Wei, Pengfei Zhang, Qiancheng Hu, Xiaolong Cheng, Chaoyong Shen, Zhixin Chen, Wen Zhuang, Yuan Yin, Bo Zhang, Hongfeng Gou, Kun Yang, Feng Bi, Ming Liu

electronic resource

Visa; Visa

Case report: Therapeutic response of front-line cadonilimab plus chemotherapy on patient with advanced lung adenocarcinoma harboring STK11 genetic aberration

Du Feng, Huixin Jiang, Gengjia Chen, Wenhui Guan, Lin Yi, Yue Zhu, Yijia Li, Gengda Huang, Bin He, Junlong Tang, Yujie Tang, Jiyuan Zeng, Wensheng Zhou, Jiayu Shi, Zhanhong Xie, Ming Liu, Xiaohong Xie, Xinqing Lin, Chengzhi Zhou

electronic resource

Visa; Visa

A surprising complete response to cadonilimab in a primary metastatic cervical cancer: a case report

Haijuan Yu, Jie Lin, Jian Chen, Lijun Chen, Jianping Zou, Bin Liu, Dan Hu, Youping Xiao, Linhao Yu, Yang Sun

electronic resource

Visa; Visa

Cadonilimab (PD-1/CTLA-4) in combination with lenvatinib in unresectable hepatocellular carcinoma (uHCC): A retrospective real-world study

Yuan, Guosheng ^{a, 1}, Chen, Yongru ^{a, 1}, Zhu, Peilin ^{a, 1}, Deng, Qiong ^b, Su, Kaiyan ^a, Liu, Jie ^c, Wang, Yan ^d, Li, Rong ^a, Li, Wenli ^a, Zang, Mengya ^a, Hu, Xiaoyun ^a, Wang, Jun-Jie ^e, Li, Qi ^{a, ⁎⁎}, Du, Yangfeng ^{f, ⁎⁎⁎}, Chen, Jinzhang ^{a, ⁎}

Infusion-Related Reactions Induced by Cadonilimab (PD-1/CTLA-4 Bispecific Antibody): Seven Case Reports

Weiting Liang, Zhijun Guo, Yunhui Zhang, Ning Yang, Chenchen Guo, Tao Liu, Hongbing Huang, Zhuojia Chen

electronic resource

Visa; Visa

Preclinical imaging evaluation of a bispecific antibody targeting hPD1/CTLA4 using humanized mice

Hou, Xingguo ^a, Liu, Song ^a, Zeng, Ziqing ^a, Wang, Zilei ^{a, c}, Ding, Jin ^a, Chen, Yan ^{a, b}, Gao, Xiangyu ^d, Wang, Jianghua ^e, Xiao, Guanxi ^e, Li, Baiyong ^e, Zhu, Hua ^{a, f, ⁎}, Yang, Zhi ^{a, f, ⁎}

Cost-effectiveness analysis of a first-line treatment with cadonilimab plus platinum-based chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer in China: COMPASSION-16 trial

Yiling Ding, Chunping Wang, Yamin Shu, Jinglin Wang, Qilin Zhang

electronic resource

Visa

The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial

Qian Qiao, Chun Han, Sisi Ye, Juan Li, Guoliang Shao, Yuxian Bai, Aibing Xu, Meili Sun, Wei Wang, Jian Wu, Ming Huang, Lijie Song, Luke Huang, Ting Liu, Wei Liu, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Li Bai

electronic resource

Visa; Visa

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.

Denna resultat visas inte till gäster.
Logga in för full Login for full tillgång.